Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.6K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.6K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.0K
The Proteasome02:18

The Proteasome

8.8K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

7.4K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Tumor-Oriented Delivery of a Dimeric STING Agonist Using an H-Ferritin Nanocage Widens the Therapeutic Window for Cancer Immunotherapy.

ACS applied materials & interfaces·2026
Same author

Molecular glue that stabilizes the LRPPRC-MET-G4 interaction complex to drive MET downregulation.

Nature communications·2026
Same author

Design, Synthesis, and Evaluation of a Novel-Labeled Small Molecule Inhibitor-Based PET/SPECT Tracer Targeting HSP90.

Journal of medicinal chemistry·2026
Same author

Crystal Facet-Polysaccharide Matching in CFS-P Nanocrystals Drives Fungal Uptake, Vacuole Destruction, and Selective Antifungal Activity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

New Binding Sites for JAK2 Inhibition in Myeloproliferative Neoplasms: Structural Insights, Therapeutic Potential, and Future Directions.

ChemMedChem·2026
Same author

Discovery of YYSW001: A Highly Selective, Orally Bioavailable JAK1 Inhibitor Achieving Efficacy under a Moderate-Inhibition Strategy with Improved Preclinical Tolerability.

Journal of medicinal chemistry·2026

相关实验视频

Updated: Jul 21, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.8K

通过DNA框架设计的嵌合体平台,可以选择性地向蛋白质降解.

Li Zhou1, Bin Yu2, Mengqiu Gao1

  • 1Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, China.

Nature communications
|July 26, 2023
PubMed
概括

研究人员开发了基于DNA框架的PROTACs (DbTACs),用于精确的蛋白质降解. 这种通用平台可以实现高通量合成和可调节的配体间距,以实现高效和选择性的目标耗尽.

更多相关视频

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
08:20

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

4.2K
Identification of Functional Protein Regions Through Chimeric Protein Construction
11:39

Identification of Functional Protein Regions Through Chimeric Protein Construction

Published on: January 8, 2019

10.5K

相关实验视频

Last Updated: Jul 21, 2025

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

9.8K
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
08:20

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization

Published on: September 2, 2021

4.2K
Identification of Functional Protein Regions Through Chimeric Protein Construction
11:39

Identification of Functional Protein Regions Through Chimeric Protein Construction

Published on: January 8, 2019

10.5K

科学领域:

  • 生物化学 生物化学
  • 分子生物学分子生物学
  • 药物发现 药物发现 药物发现

背景情况:

  • 开发针对蛋白质分解的嵌合体 (PROTACs) 需要一个通用平台来精确降解感兴趣的蛋白质 (POI).
  • 现有的 PROTAC 开发面临广泛适用性和高效合成方面的挑战.

研究的目的:

  • 使用DNA框架为PROTAC开发设计一个通用平台.
  • 为了证明基于DNA框架的PROTACs (DbTACs) 在向蛋白质降解中的有效性.

主要方法:

  • 利用DNA四面体作为POI和E3结合酶连接体的精确空间排列的刚性模板.
  • 采用简单的生物对角化学和自组装,用于DbTACs的高吞吐量合成.
  • 操纵了从8 Å到57 Å的配体间距,并测试了各种弹头 (小分子,抗体,DNA动机).

主要成果:

  • 具有优化链接长度的DbTAC显示降解率和结合亲和力增加.
  • 双特异性DbTACs可实现多目标耗尽和蛋白质亚型的选择性降解.
  • DbTACs在降解各种细胞区中的各种酶和转录因子等目标方面表现出强大的有效性.

结论:

  • 模块化DNA框架为PROTAC开发中的合基质提供了一个通用平台.
  • DbTAC提供了对一般降解剂设计原则的见解,并为药物发现提供了有前途的战略.